Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode

被引:181
作者
Gervasoni, N
Aubry, JM
Bondolfi, G
Osiek, C
Schwald, M
Bertschy, G
Karege, F
机构
[1] Univ Hosp Geneva, Dept Psychiat, Adult Psychiat Serv, Geneva, Switzerland
[2] Univ Hosp Geneva, Dept Psychiat, Neuropsychiat Serv, Geneva, Switzerland
关键词
major depression; platelet brain-derived neurotrophic factor; complete remission; antidepressant drug;
D O I
10.1159/000085725
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We had previously reported decreased serum brain-derived neurotrophic factor ( BDNF) levels in depressed patients. In the present study, we tested the hypothesis that antidepressant treatment would normalize serum BDNF levels, at least in a subgroup of patients. Major depressed patients ( 15 females and 11 males) diagnosed according to DSM-IV criteria and healthy controls ( 13 females and 13 males) participated in this study. Serum BDNF was assayed with the ELISA method for depressed and remitted patients and the severity of depression was evaluated with the Montgomery-Asberg Depression Rating Scale. An analysis of variance showed that treatment had an effect [ F( 1, 24) = 4.46, p = 0.045] on the normalization of serum BDNF levels. We also found a correlation between the severity of depression ( r = 0.51, p = 0.008), the pretreatment BDNF levels ( r = 0.62, p = 0.001) and the difference in serum BDNF levels after antidepressant treatment. These results suggest that antidepressant treatment has a positive effect on serum BDNF levels and support the hypothesis of neurotrophic factor involvement in affective disorders. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:234 / 238
页数:5
相关论文
共 32 条
[1]   Neurotrophins and depression [J].
Altar, CA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (02) :59-61
[2]  
APFEL SC, 1997, CLIN APPL NEUROTROPH
[3]  
ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5
[4]   Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms [J].
Bonni, A ;
Brunet, A ;
West, AE ;
Datta, SR ;
Takasu, MA ;
Greenberg, ME .
SCIENCE, 1999, 286 (5443) :1358-1362
[5]   Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication [J].
Chen, B ;
Dowlatshahi, D ;
MacQueen, GM ;
Wang, JF ;
Young, LT .
BIOLOGICAL PSYCHIATRY, 2001, 50 (04) :260-265
[6]   Brain-derived neurotrophic factor is reduced in Alzheimer's disease [J].
Connor, B ;
Young, D ;
Yan, Q ;
Faull, RLM ;
Synek, B ;
Dragunow, M .
MOLECULAR BRAIN RESEARCH, 1997, 49 (1-2) :71-81
[7]   Antidepressants and neuroplasticity [J].
D'Sa, C ;
Duman, RS .
BIPOLAR DISORDERS, 2002, 4 (03) :183-194
[8]  
Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597
[9]   Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains [J].
Durany, N ;
Michel, T ;
Kurt, J ;
Cruz-Sánchez, FF ;
Cervós-Navarro, J ;
Riederer, P .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2000, 18 (08) :807-813
[10]   The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function [J].
Egan, MF ;
Kojima, M ;
Callicott, JH ;
Goldberg, TE ;
Kolachana, BS ;
Bertolino, A ;
Zaitsev, E ;
Gold, B ;
Goldman, D ;
Dean, M ;
Lu, B ;
Weinberger, DR .
CELL, 2003, 112 (02) :257-269